Skip to main content
. 2023 Sep 13;23:660. doi: 10.1186/s12884-023-05970-2

Table 1.

Patient Demographics Prior to and Post-PSM

Variables Pre-PSM Post-PSM
Dydrogesterone (N = 2,368) Allylestrenol (N = 989) P-value SMD Dydrogesterone (N = 989) Allylestrenol (N = 989) P-value SMD
Age (Years) 33.00 [30.00, 36.00] 33.00 [30.00, 36.00] 0.035 0.110 33.00 [30.00, 36.00] 33.00 [30.00, 36.00] 0.396 0.052
Type of infertility (%) 0.189 0.051 0.368 0.043
 Primary 1217 (51.4) 483 (48.8) 462 (46.7) 483 (48.8)
 Secondary 1151 (48.6) 506 (51.2) 527 (53.3) 506 (51.2)
Years of infertility 4.00 [2.00, 6.00] 3.00 [2.00, 5.00] < 0.001* 0.119 3.00 [2.00, 5.00] 3.00 [2.00, 5.00] 0.771 0.029
Basal hormone level
 FSH (mIU/mL) 5.88 [4.86, 7.15] 5.97 [4.89, 7.09] 0.477 0.061 5.80 [4.73, 7.10] 5.97 [4.89, 7.09] 0.062 0.063
 LH (mIU/mL) 4.00 [2.70, 5.75] 3.78 [2.25, 5.52] < 0.001* 0.109 3.86 [2.44, 5.76] 3.78 [2.25, 5.52] 0.148 0.062
 E2 (pg/mL) 36.29 [26.38, 48.52] 34.84 [24.56, 45.86] 0.015 0.051 34.64 [25.16, 45.99] 34.84 [24.56, 45.86] 0.515 0.022
 AFC 13.00 [9.00, 20.00] 14.00 [9.00, 21.00] 0.003* 0.109 14.00 [9.00, 22.00] 14.00 [9.00, 21.00] 0.607 0.029
 AMH (ng/ml) 2.96 [1.74, 4.90] 2.99 [1.72, 4.77] 0.558 0.065 2.96 [1.71, 4.89] 2.99 [1.72, 4.77] 0.764 0.040
 Progesterone (ng/ml) 0.45 [0.26, 0.68] 0.22 [0.13, 0.35] < 0.001* 0.008 0.35 [0.20, 0.58] 0.22 [0.13, 0.35] < 0.001* 0.018
Hormone level on the day of hCG
 FSH (mIU/mL) 12.41 [9.74, 16.09] 12.39 [9.87, 15.24] 0.264 0.112 12.07 [9.10, 15.42] 12.39 [9.87, 15.24] 0.099 0.009
 E2 (pg/ml) 26.94 [16.50, 30.00] 30.00 [16.74, 30.00] 0.386 0.044 27.80 [16.45, 30.00] 30.00 [16.74, 30.00] 0.368 0.015
 LH (mIU/mL) 1.61 [0.99, 2.65] 1.46 [0.93, 2.74] 0.065 0.017 1.38 [0.84, 2.55] 1.46 [0.93, 2.74] 0.151 0.022
 AFC 12.00 [7.00, 17.00] 12.00 [8.00, 17.00] 0.068 0.060 12.00 [8.00, 18.00] 12.00 [8.00, 17.00] 0.850 0.030
 Progesterone (ng/ml) 0.87 [0.58, 1.24] 0.60 [0.36, 0.97]   0.001* 0.038 0.78 [0.47, 1.18] 0.60 [0.36, 0.97] < 0.001* 0.049
Ovarian Stimulation Protocol (%) < 0.001* 0.823 0.994 0.038
 PPOS 64 (2.7) 32 (3.2) 35 (3.5) 32 (3.2)
 Mild stimulation protocol 144 (6.1) 21 (2.1) 21 (2.1) 21 (2.1)
 GnRH antagonist protocol 404 (17.1) 290 (29.3) 302 (30.5) 290 (29.3)
 Modified long protocol 404 (17.1) 394 (39.8) 381 (38.5) 394 (39.8)
 Long protocol 1143 (48.3) 171 (17.3) 171 (17.3) 171 (17.3)
 Luteal phase stimulation protocol 118 (5.0) 46 (4.7) 43 (4.3) 46 (4.7)
 Others 91 (3.8) 35 (3.5) 36 (3.6) 35 (3.5)
Number of Miscarriages 0.009* 0.119 0.188 0.112
 0 2125 (89.7) 902 (91.2) 888 (89.8) 902 (91.2)
 1 216 (9.1) 70 (7.1) 88 (8.9) 70 (7.1)
 2 21 (0.9) 11 (1.1) 11 (1.1) 11 (1.1)
≥ 3 6 (0.3) 2 (0.2) 2 (0.2) 2 (0.2)

PSM propensity score matching, SMD standardized mean difference, FSH follicle stimulating hormone, LH luteinizing hormone; E2 estradiol, AFC antral follicle count, AMH anti- Müllerian hormone, hCG human chorionic gonadotropin, PPOS progestin-primed ovarian stimulation, GnRH gonadotropin-releasing hormone

*P < 0.05